0307 GMT - Sigma Healthcare's elevated profile from its impending merger with Chemist Warehouse and its likely inclusion as one of Australia's 100 largest listed companies earn the pharmaceutical supplier a new bull at Morgans. Analyst Scott Power raises his recommendation on the stock to add from hold, telling investors that Sigma will attract significant passive buying from funds if, as he expects, it is included in Australia's S&P/ASX 100 and other global indexes. He adds a 30% liquidity premium to his valuation as a result. Target price rises 35% to A$2.98. Shares are up 0.4% at A$2.68. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
December 16, 2024 22:07 ET (03:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.